About Fibrinogen C domain-containing protein 1
Fibrinogen C domain-containing protein 1 (FIBCD1) is a protein
from Homo sapiens identified by UniProt accession
Q8N539, 461 residues long.
MolForge cross-references it against 0 known binders and
55 disease associations.
Target properties
| Protein name | Fibrinogen C domain-containing protein 1 |
| UniProt accession | Q8N539 |
| Gene | FIBCD1 |
| Organism | Homo sapiens |
| Length | 461 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (55)
Diseases linked to this target (Open Targets).
- body mass index · score 0.38
- body weight · score 0.28
- body fat percentage · score 0.27
- type 2 diabetes mellitus · score 0.25
- insomnia measurement · score 0.25
- body height · score 0.25
- lean body mass · score 0.23
- fat body mass · score 0.23
- waist circumference · score 0.14
- hepatocellular carcinoma · score 0.07
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8N539-F1 | alphafold | PREDICTED | 80.08 | — |
Amino-acid sequence (461 residues)
MVNDRWKTMG GAAQLEDRPR DKPQRPSCGY VLCTVLLALA VLLAVAVTGA VLFLNHAHAP GTAPPPVVST GAASANSALV TVERADSSHL SILIDPRCPD LTDSFARLES AQASVLQALT EHQAQPRLVG DQEQELLDTL ADQLPRLLAR ASELQTECMG LRKGHGTLGQ GLSALQSEQG RLIQLLSESQ GHMAHLVNSV SDILDALQRD RGLGRPRNKA DLQRAPARGT RPRGCATGSR PRDCLDVLLS GQQDDGVYSV FPTHYPAGFQ VYCDMRTDGG GWTVFQRRED GSVNFFRGWD AYRDGFGRLT GEHWLGLKRI HALTTQAAYE LHVDLEDFEN GTAYARYGSF GVGLFSVDPE EDGYPLTVAD YSGTAGDSLL KHSGMRFTTK DRDSDHSENN CAAFYRGAWW YRNCHTSNLN GQYLRGAHAS YADGVEWSSW TGWQYSLKFS EMKIRPVRED R
Explore Fibrinogen C domain-containing protein 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets